Company intelligence / Profile preview

Avio

Kuala Lumpur, Malaysia

Ownership: Private
Development stage: Other

Overview

Avio Health is a clinical AI company that uses advanced data analytics and machine learning to unify, interpret, and synthesize fragmented health data. Its AI platform processes medical records, biomarkers, wearable data, genomics, and imaging, delivering actionable insights for preventive, personalized healthcare. The platform is used in longevity and functional medicine clinics, helping physicians detect early health risks and personalize treatment and supplementation. Avio Health’s technology is currently deployed in pilot programs in Southeast Asia and the US, with plans to launch a direct-to-consumer dashboard.

Therapeutic areas: Other
Modalities: AI-powered clinical analyticsSoftware Platform
Industry: Digital Health Medical Devices

Partnerships

Emagene Life

Beyond the preview

Go deeper on Avio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avio.

Explore the full profile